Health Logic appoints Barthel CEO

Mr. George Kovalyov reports

HEALTH LOGIC INTERACTIVE IS PLEASED TO ANNOUNCE THE APPOINTMENT OF EXPERIENCED MEDTECH EXECUTIVE AS CEO

Health Logic Interactive Inc. has hired David Barthel as its chief executive officer.

Mr. Barthel is an experienced executive leader in the medical device space with a successful record.

Mr. Barthel founded The SmartPill and led the company as chief executive officer and president until its acquisition by medical device giant Medtronic. Mr. Barthel took The SmartPill company from its initial patent through the entire product development process, including raising over $70-million (U.S.) in multiple financing rounds. Mr. Barthel led his team through multiple clinical trials, manufacturing, Food and Drug Administration approval, and successful insurance reimbursement. After the acquisition by Medtronic, Mr. Barthel joined the company as area vice-president, GIH southeast division. Mr. Barthel has also been active advising other leading medtech companies, including Henry Schein’s orthopedic surgical instrumentation business.

Mr. Barthel earned a bachelor of arts degree from St. Norbert College in De Pere, Wis., and an MBA from Lake Forest Graduate School of Management in Lake Forest, Ill.

George Kovalyov, director, stated: “We’re grateful to welcome an executive of David’s calibre and applicable experience to our young and growing company. David will be an invaluable asset and esteemed leader as we progress through 2021, raising capital and achieving milestones. David’s success of leading a medical device company through the product development process and to its ultimate sale to Medtronic, along with his continued upward trajectory of working at both Medtronic and Henry Schein, brings a desirable balance of both start-up hunger and big-pharma experience to build the best company from the start.”

About Health Logic Interactive Inc.

Health Logic plans to develop and commercialize novel technologies. At the present time, the company is not engaged in active business operations. The company intends to acquire and commercialize consumer-focused health care technologies that address areas of unmet needs. However, to date, it has not entered into any binding agreements for such acquisitions, and there can be no guarantee that the company will be able to identify, negotiate and complete such acquisitions, and raise the necessary financings for such acquisitions or for the development of its business, should it be able to complete such acquisitions.